Los Angeles — and other modern megacities — conjure increasingly unique genetic profiles that point the way to a new medical industry: Call it urbo-pharmaceuticals. Investors are needed.
Is there a pill that might inoculate us from smog?
Is there a gene we can target that would make us resistant to resurgent infectious diseases?
And is there a way to use genetic data to insulate new immigrants from some of the metabolic challenges of living in a new land of plenty?
Welcome to the slowly emerging world of environmental medicine and its inevitable outgrowth, environmental pharmaceuticals: compounds specifically suited for mitigating the physiological challenges of mega-city life in the 21st century. read more »